(1S,2R,3S,4R)-4-(7-(2-(3-hydroxybenzylidene)hydrazinyl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)cyclopentane-1,2,3-triol

ID: ALA3623467

Chembl Id: CHEMBL3623467

PubChem CID: 122192512

Max Phase: Preclinical

Molecular Formula: C19H23N7O4S

Molecular Weight: 445.51

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCSc1nc(N/N=C/c2cccc(O)c2)c2nnn([C@@H]3C[C@H](O)[C@@H](O)[C@H]3O)c2n1

Standard InChI:  InChI=1S/C19H23N7O4S/c1-2-6-31-19-21-17(24-20-9-10-4-3-5-11(27)7-10)14-18(22-19)26(25-23-14)12-8-13(28)16(30)15(12)29/h3-5,7,9,12-13,15-16,27-30H,2,6,8H2,1H3,(H,21,22,24)/b20-9+/t12-,13+,15+,16-/m1/s1

Standard InChI Key:  IYFJEZZMXGJZFM-ASPHORIHSA-N

Alternative Forms

  1. Parent:

    ALA3623467

    ---

Associated Targets(Human)

A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
P2RY12 Tclin Purinergic receptor P2Y12 (2369 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 445.51Molecular Weight (Monoisotopic): 445.1532AlogP: 0.90#Rotatable Bonds: 7
Polar Surface Area: 161.80Molecular Species: NEUTRALHBA: 12HBD: 5
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 5#RO5 Violations (Lipinski): 1
CX Acidic pKa: 9.19CX Basic pKa: 4.71CX LogP: 2.13CX LogD: 2.11
Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.15Np Likeness Score: -0.90

References

1. Wang Y, Yan H, Ma C, Lu D..  (2015)  Synthesis and anticancer activities of novel 8-azapurine carbocyclic nucleoside hydrazones.,  25  (20): [PMID:26364944] [10.1016/j.bmcl.2015.09.002]
2. Zhao Z, Wang Y, Tian N, Yan H, Wang J..  (2021)  Synthesis and biological evaluation of N 6 derivatives of 8-azapurine as novel antiplatelet agents.,  12  (8.0): [PMID:34458743] [10.1039/D1MD00128K]

Source